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Family-based associations in measures of
psychological distress and quality of life in a
cardiac screening clinic for inheritable cardiac
diseases: a cross-sectional study
Catherine McGorrian1,2*, Charlene McShane2, Colin McQuade1, Ted Keelan1,3, Jim O Neill1,3, Joseph Galvin1,3,
Kevin Malone4, Niall G Mahon1 and Mary Codd2
Abstract
Background: Family-based cardiac screening programmes for persons at risk for genetic cardiac diseases are now
recommended. However, the psychological wellbeing and health related quality of life (QoL) of such screened
patients is poorly understood, especially in younger patients. We sought to examine wellbeing and QoL in a
representative group of adults aged 16 and over in a dedicated family cardiac screening clinic.
Methods: Prospective survey of consecutive consenting patients attending a cardiac screening clinic, over a 12
month period. Data were collected using two health measurement tools: the Short Form 12 (version 2) and the
Hospital Anxiety and Depression Scale (HADS), along with baseline demographic and screening visit-related data.
The HADS and SF-12v.2 outcomes were compared by age group. Associations with a higher HADS score were
examined using logistic regression, with multi-level modelling used to account for the family-based structure of the
data.
Results: There was a study response rate of 86.6%, with n=334 patients providing valid HADS data (valid response
rate 79.5%), and data on n=316 retained for analysis. One-fifth of patients were aged under 25 (n=61). Younger
patients were less likely than older to describe significant depression on their HADS scale (p<0.0001), although
there were overall no difference between the prevalence of a significant HADS score between the younger and
older age groups (18.0% vs 20.0%, p=0.73). Significant positive associates of a higher HADS score were having lower
educational attainment, being single or separated, and being closely related to the family proband. Between-family
variance in anxiety and depression scores was greater than within-family variance.
Conclusions: High levels of anxiety were seen amongst patients attending a family-based cardiac screening clinic.
Younger patients also had high rates of clinically significant anxiety. Higher levels of anxiety and depression tends
to run in families, and this has implications for family screening and intervention programmes.
Keywords: Screening, Inherited cardiac diseases, Channelopathy, Sudden cardiac death, Sudden arrhythmic death
syndrome, Anxiety, Depression, Family-based evaluation
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Background
A number of cardiac conditions which can cause cardiac
arrhythmia and even sudden cardiac death (SCD) are now
known to be of genetic etiology. Tagetted, family-based
clinical and genetic cardiac screening for at-risk families is
now recommended by many agencies, with the aim of early
identification of potentially dangerous cardiac diseases [1].
These diseases include certain cardiomyopathies as well as
the cardiac “ion channelopathy” disorders. In the majority
of cases, these conditions are inherited in an autosomal
dominant manner [2].
In cases where a person dies suddenly and unexpectedly,
with no pathological findings at autopsy examination to
explain the death, the event is termed Sudden Arrhythmic
Death Syndrome, or SADS [3]. Previous studies have
shown that in up to half of families with a SADS bereave-
ment, an inherited pro-arrhythmic cardiac condition can
be identified in living family members [4-8]. Appropriate
and timely management of these cardiac conditions can
reduce the risk of a sudden death [9,10]. Family cardiac
screening clinics perform protocol-driven clinical cardiac
screening both in families with a known history of an
inheritable cardiac disease, and in families with a SADS
bereavements [11].
One feature of SADS death is the unexpectedness of
the bereavement. This may result in a more difficult
grief reaction [12]. There can also be fearfullness for the
physical health and wellbeing of other family members,
and the anxiety for parents in particular can be very
great [13]. In our clinic, we have observed that parents
will prioritise family screening in the family’s teenagers
and young adults, because of the perceived threat to
their health from an undetected cardiac condition.
Whilst the psychological status of patients attending for
cardiac screening because of an inherited cardiac disease
risk has been examined in a number of studies [13-17],
there is no specific information on anxiety levels in
younger adults coming for such screening, compared
with older adults. We sought to define the anxiety and
depression burden associated with family-based cardiac
screening, to examine whether these traits cluster within
families, and to examine the associates of higher levels
of anxiety and depression states in this population.
Methods
Study population
From September 2010 until September 2011, all persons
aged 16 and older, attending for screening at a dedicated
family heart screening clinic in a single tertiary cardiology
referral centre, were approached for study recruitment.
Patients were referred by general practitioner-, specialist-
or self-referral, because of either a family history of a
known or suspected genetic cardiac disease (typically car-
diomyopathy or channelopathy), or because of a family
history of SADS. At clinic visit, patients met with a
specialist nurse counsellor and underwent protocol-driven
clinical cardiac testing with ECG and echocardiogram (for
families at risk of cardiomyopathy); ECG, Holter, and
Treadmill testing (for families at risk of a channelopathy)
and all four tests in families with a history of SADS.
Patients then underwent a family-based consultation
with a cardiologist with expertise in inherited cardiac
diseases, and further assessment with tests such as
ajmaline provocation testing or genetic testing were
scheduled as indicated [8].
In this study, patients who consented completed a
Hospital Anxiety and Depression (HADS) survey [18]
and a Short Form-12 version 2 (SF-12v2) survey [19],
whilst in the clinic but prior to their clinical assessment.
Study data were collected on patient demographic
details including age, sex, marital status, education sta-
tus, whether this was a first or follow-up screening visit,
and the indication for screening. Note was made as to
whether patients had a family history of a SADS or SCD
bereavement, and their relationship to the family index
case or “proband”. Patients who were themselves the
family proband were excluded from this analysis. All
families were attributed a numeric family identifer.
Ethical approval was granted by the Mater Misericordiae
University Hospital Research Ethics Committee, and
patients provided informed consent prior to study entry.
Study instruments
The study instruments chosen were the SF-12v2 and
the HADS. The SF-12 was first devised in 1994 and
revised in 1998, and is derived from the longer SF-36,
based on items from the Medical Outcomes study.
The SF-12v2 yields a physical health component sum-
mary (PCS-12) and a mental health component summary
(MCS-12), as well as eight subscores in the domains
of Physical Functioning (PF), Role-Physical (RP),
Bodily Pain (BP), General Health (GH), Vitality (VT),
Social Functioning (SF), Role-Emotional (RE) and Mental
Health (MH). For version 2 of the SF-12, reliability
estimates are quoted for the PCS-12 of 0.89, and the
MCS-12 of 0.86 [19].
The HADS score was designed as a screening tool
to detect clinically significant anxiety and depression
in patients coming to an outpatients setting [20]. It
consists of 14 items, seven measuring anxiety and
seven measuring depression, and scores for each subscale
range from 0 to 21. Mean Cronbach’s alpha for the anxiety
subscale (HADS-A) is 0.83, and for the depression
subscale (HADS-D) was 0.82 [21]. Cut-point scores
for possible “cases” have been suggested at 8 to 10
[20], and for definite “cases”, 11 or more [18,20]. For
this study, a cut off of 11 or greater was used to define
case status.
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Statistical analysis
Simple descriptive statistics were used to describe the base-
line demographic features of the population. With regards
to the HADS findings, the anxiety and depression sub-
scales (HADS-A and HADS-D respectively) were calcu-
lated. For the SF-12v2 analysis, T scores were derived as
described by Ware using the 1998 US norms [19], and the
PCS and MCS were described by age in groups. Analysis of
variance was used to examine the association of the
HADS-A, HADS-D, PCS and MCS with age. As the obser-
vations (patients) are nested within families, between- and
within-family variance was examined for the subscales.
The psychometric properties of the HADS in this popula-
tion were examined using Cronbach’s alpha to assess in-
ternal consistency [22], and the correlations between the
HADS and SF-12 scales were examined using a pairwise
correlation matrix. Frequencies of endorsing the individual
data items in the HADS questionnaire were examined by
age group, with comparisons between groups made with
the Pearson’s chi square test and the Fisher’s exact test.
A p value of <0.05 was accepted as statistically significant.
Logistic regression models were fitted to examine the
associations between demographic and patient-specific
factors and a high HADS score (score of ≥11 on either
subscale, as above). Simple logistic regression was used to
examine the individual factors, with adjusted multivariable
logistic regression models were fitted which included the
covariables which had reached statistical significance at at
least the 10% level in the simple models. Multivariable
models were fitted both with and without a random
effects term to indicate family identification number.
All analyses were performed with Intercooled Stata 12
(StataCorp, Texas).
Results
Of the total population approached, 364 of 420 patients
consented and provided data to the study, with 334
respondants providing complete and valid HADS data
(response rate of 86.6%, valid response rate 79.5%). A
small number of patients (6.6%) came because of a sus-
pected inherited condition in themselves (with no family
history) and were excluded from further analysis. Of the
study n=316, the mean age was 35.94 years, stadard de-
viation (SD) 13.03, range 15 to 72, with nearly one-fifth
(n=61) patients being aged 24 or younger. Table 1 shows
the demographics of the study population. Most patients
came with a screening indication of a known family con-
dition (either a channelopathy or cardiomyopathy), with
23.4% presenting because of a history of SADS or sud-
den infant death syndrome (SIDS). Of the younger
patients (age ≤25), over two-fifths attended for cardio-
myopathy screening (42.6%, n=26), whereas 27.9%
(n=17) attended for channelopathy screening, and 18.3%
(n=11) attended for SADS screening. Over half of the
younger patient group were female (54.1%, n=33), and
62.3% (n=38) had a family history of SCD or SADS.
Internal consistency of the HADS and SF-12 measures
were assessed. Cronbach’s alpha for the HADS-A sub-
scale was 0.828, with an average inter-item correlation of
0.411. For the HADS-D subscale, Cronbach’s alpha for
the HADS-D subscale was 0.764, with an average inter-
item correlation of 0.338. Cronbach’s alpha for the SF
items was 0.855, with an average inter-item correlation
of 0.349. Pairwise correlations for the HADS-A, HADS-D,
PCS and MCS are shown in Table 2, with strong and
Table 1 Baseline demographics on n=316 consenting
consecutive family heart screening patients with valid
psychological wellbeing data
Variables N=316
Age in years: Mean (SD) 35.94 (13.03)
Male sex: n(%) 148 (46.8%)
Clinic visit status:
First visit: n(%) 248 (78.5%)
Second or subsequent visit:n(%) 68 (21.5%)
Education level (of n=300 patients):
Completed primary school: n(%) 62 (20.7%)
Completed secondary school: n(%) 77 (25.7%)
Completed a secondary diploma: n(%) 75 (25.0%)
Completed a degree: n(%) 86 (28.7%)
Marital status:
Married or cohabiting: n(%) 131 (41.5%)
Single: n(%) 175 (55.4%)
Widowed or divorced: n(%) 10 (3.2%)
Reason for screening:
SADS or SIDS family history: n(%) 74 (23.4%)
Cardiomyopathy screening: n(%) 146 (46.2%)
Channelopathy screening: n(%) 74 (23.4%)
Other screening indication: n(%) 22 (7.0%)
Relationship to family index case:
First degree relative: n(%) 228 (72.2%)
Second degree relative or greater: n(%) 88 (27.8%)
Family History of SCD: n(%) 196 (62.8%)
Table 2 Pairwise correlation coefficients for the the key
HADS and SF-12v2 subscales
HADS-A HADS-D PCS MCS
HADS-A r=1.00 - - -
HADS-D r= 0.60; p<0.0001 r=1.00 - -
PCS r=−0.10; p=0.08 r= −0.18; p=0.002 r=1.00 -
MCS r=−0.61;
p<0.0001
r= −0.63;
p<0.0001
r=− 0.21;
p=0.0003
r=1.00
HADS-A Hospital anxiety and depression scale anxiety subscale HADS-D.
Hospital anxiety and depression scale depression subscale PCS. Physical health
component summary MCS Mental health component summary.
Footnote: Where r is the Pearson correlation coefficient.
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statistically significant positive correlations between the
HADS-A, HADS-D, and MCS.
Key results for both the SF-12 and HADS scores are
shown in Table 3, for the whole population and by age
subgroups. HADS-D scores increased with age (p<0.0001),
indicating increasing prevalence of depressive symptoms,
and PCS-12 decreased with age (p=0.01), indicating wor-
sening physical health. Specific comparisons of the HADS
measures in the younger age group compared with the
older patients are shown in Table 4. Further information
on the SF-12v2 subscale measures by sex and by age group
is available in Table 5.
In total, 62 patients had a HADS-A score of 11 or
greater, used in this study to suggesting a significant risk
of clinically important anxiety and/or depression or “case
status”. Four patients had a HADS-D score of 11 or
greater, and all of those also had a high HADS-A score.
There was no difference in the frequency of a significant
HADS score in the under 25 years group compared with
older patients (18.0% (11/61) vs 20.0% (51/254), χ2=0.12,
p=0.73). Table 6 shows the results of a simple logistic re-
gression models with a HADS-A or HADS-D score of 11
or greater as the dependent variable, adjusted for age and
sex. Negative associations at under the 10% level of signifi-
cance were noted between a clinically significant HADS
score and being male, having a degree-level eduation, and
being married. These associations were robust in a multi-
variable adjusted model (Table 7: model 1), where signifi-
cant negative associations were again seen between having
a clinically significant HAD score and being married or
cohabiting vs single / divorced / widowed (Odds ratio
(OR) 0.42, 95% confidence interval (CI) 0.19 to 0.92), and
having education to third level or degree level (OR 0.31,
95% CI 0.14 to 0.71); with a trend towards signifi-
cance for male sex (OR 0.54, 95% CI 0.29 to 1.01).
There was a significant positive association between a
clinically significant HADS score and being closely related
to the family proband (OR 2.91, 95% CI 1.26 to 6.73).
Since patients in this study were undergoing their
screening in a family context, the HADS and SF-12v2
scores were also evaluated by family, using a unique iden-
tification number for each family (n=135 families). For
mean subscale score for the HADS and SF-12v2 subscales,
between-family standard deviations were greater than
within-family variations (Table 8). Finally, the effects of
family on the regression model were examined using a
random effects variable for the family unique identifier
number (Table 7: model 2). Robust negative associations
were observed between a clinically significant HADS score
and the independent variables already described, although
model fit as estimated by the log likelihood did not benefit
from the addition of the random effects term.
Discussion
We describe high rates of significant psychological distress
in our population of patients attending for family heart
screening evaluation, with 19.2% of patients showing sig-
nificant distress on their HADS scale. This distress was
Table 3 Key HADS and SF-12v2 results, comparing the findings by age group
All persons Persons aged
≤ 24
Persons aged
25 -39
Persons aged
40-54
Persons aged
55+
F statistics,
p value*
Hospital Anxiety and Depression Scale
n 316 61 143 75 37
HADS-A: Mean (SD) 6.87 (3.96) 6.6 (3.94) 7.09 (3.94) 7.24 (3.77) 5.68 (4.33) F=1.59, p=0.19
HADS-D: Mean (SD) 2.83 (2.70) 1.82 (2.04) 2.46 (2.29) 4.08 (3.09) 3.35 (3.24) F=10.42, p<0.0001
Short Form 12 version 2 scale
n 294 57 135 70 32
PCS-12: Mean (SD) 51.62 (8.07) 53.34 (7.04) 52.38 (7.66) 50.26 (8.55) 48.32 (9.33) F=3.81, p=0.011
MCS-12: Mean (SD) 49.63 (10.51) 50.37 (10.12) 49.41 (9.47) 47.87 (12.28) 53.11 (10.73) F=1.95, p=0.12
*From an analysis of variance (ANOVA) model with age group (in categories) as the indendent variable; F statistic and p value given for the model as a whole.
HADS-A Hospital anxiety and depression scale anxiety subscale HADS-D Hospital anxiety and depression scale depression subscale SD Standard deviation PCS-12.
Physical health component summary MCS-12 Mental health component summary.
Table 4 HADS and SF-12v2 results, with specific focus on the younger patients
Younger group (age<25) (n=60) Older group (age 25 and over) (n=252) Test statistic, p value
HADS-A: Mean (SD) 6.60 (3.94) 6.93 (3.97) t=0.57, p=0.56
HADS-D: Median (IQR) 1 (3) 2 (4) z=3.47, p=0.0005
PCS-12: Mean (SD) 53.34 (7.04) 51.21 (8.26) t=−1.80, p=0.074
MCS-12: Mean (SD) 50.37 (10.12) 49.46 (10.62) t=−0.59, p=0.56
HADS-A Hospital anxiety and depression scale anxiety subscale HADS-D Hospital anxiety and depression scale depression subscale SD Standard deviation PCS-12.
Physical health component summary MCS-12 Mental health component summary.
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primarily related to high measures of anxiety. Younger
persons also had high rates of significant HADS scores,
with 18.2% of persons aged under 25 having significant
distress on their HADS scale. However, HADS items rela-
ting to depression were more commonly endorsed in the
older groups. We identified a number of parameters as
significant predictors of greater distress at family scree-
ning evaluation. Patients who had lower levels of educa-
tion, and who were not married, were more likely to have
a significant HADS score, and there was a trend towards
greater distress in female patients. Patients who were
more closely related to the family proband were also at
greater risk of a higher anxiety and depression score.
In our analysis, the particular screening indication
(SADS vs channelopathy vs cardiomyopathy) was not
associated with a difference in the health related quality of
life (QoL) or psychological stress measures. This contrasts
with another study, which noted poorer scores in the
mental and physical health domains in patients attending
for genetic screening for HCM, compared with those
attending for genetic screening for arrhythmia or LQTS
[14]. However this difference may be due to differences in
the screening populations: our population were attending
because of a family history and were mostly asympto-
matic, whereas the other study population had a greater
prevalence of both clinical HCM and symptoms. Female
patients had a greater risk of a higher HAD score in our
analysis, and a higher risk of heart-focused anxiety in
women has been noted elsewhere also [23]. Girls who
have been bereaved of a sibling are more at risk of higher
grief and trauma scores than boys [24].
It is notable that a family history of SCD was not asso-
ciated with higher HADS scores in our analysis. This is in
keeping with the study by Christiaans and colleagues [25],
where perceived risk of SCD was associated with psycho-
logical distress, but a family history of SCD was not.
Conversely, another study has shown that using a different
measure of distress, heart-focused levels of anxiety are
higher in screening patients who have lost a close relative
to sudden death [23]. We did not have data on the recency
of the family bereavement (if any), and this may affect the
level of distress encountered. However, being more closely
related to the family index case or proband (whether alive
Table 5 Data table showing means and standard deviations of the sub scales of SF12v2. Scores shown are the mean
(standard deviation) of the subscale T scores, normed to 1998 US data
PCS MCS PF RP BP GH VT SF RE MH
Men Under 25 years (n=27) 53.60
(6.40)
51.14
(8.34)
52.65
(8.70)
53.25
(6.48)
52.54
(9.10)
52.49
(9.19)
54.45
(7.89)
53.58
(6.15)
49.87
(7.49)
50.99
(9.16)
25-39 years (n=72) 53.10
(7.08)
49.49
(8.21)
51.33
(10.07)
52.75
(7.89)
53.77
(7.04)
50.39
(9.85)
51.99
(9.19)
51.72
(7.73)
50.41
(8.29)
49.70
(9.36)
40-54 years (n=21) 51.98
(7.39)
49.50
(11.93)
52.38
(7.50)
51.52
(7.10)
51.88
(10.77)
46.38
(10.52)
55.07
(9.91)
48.76
(11.21)
49.47
(8.91)
50.13
(10.05)
≥55 years (n=17) 49.72
(6.75)
54.61
(8.48)
48.74
(10.39)
53.30
(5.59)
51.33
(8.37)
48.73
(9.02)
53.28
(8.93)
52.08
(9.31)
50.49
(9.25)
54.18
(8.87)
Women Under 25 years (n=30) 53.11
(7.67)
49.68
(11.59)
50.74
(11.09)
53.64
(5.63)
54.16
(8.06)
51.86
(8.50)
52.62
(9.32)
51.20
(8.10)
47.60
(10.30)
52.15
(8.40)
25-39 years (n=63) 51.56
(8.25)
49.32
(10.80)
49.86
(9.93)
51.38
(8.09)
52.97
(9.48)
49.95
(8.95)
52.39
(9.26)
48.68
(10.56)
48.51
(10.39)
50.10
(9.73)
40-54 years (n=49) 49.53
(8.97)
47.18
(12.48)
45.56
(12.28)
49.44
(8.61)
51.48
(9.25)
49.58
(7.56)
49.68
(10.17)
46.67
(11.86)
46.79
(11.81)
46.84
(9.68)
≥55 years (n=15) 46.73
(11.64)
51.41
(12.91)
42.51
(12.88)
47.66
(10.37)
52.01
(9.33)
50.53
(6.18)
48.42
(9.67)
50.89
(9.73)
47.51
(12.12)
50.72
(11.16)
PCS Physical health component summary MCS Mental health component summary PF Physical Functioning RP Role-Physical BP Bodily Pain.
GH General Health VT Vitality SF Social Functioning RE Role-Emotional MH Mental Health.
Table 6 Simple logistic regression, with a significant
HADS score as the outcome variable, with all models
adjusted for age and sex
Odds
ratio
95% confidence
interval
P
value
Age (in years) 0.99 0.97, 1.01 0.41
Male sex 0.51 0.28, 0.91 0.02
First visit (vs subsequent) 0.95 0.49, 1.87 0.89
Degree level education vs
lower
0.38 0.18, 0.83 0.014
Marital status: Married vs
single/widowed / divorced
0.51 0.24, 1.07 0.074
Screening reason: SADS vs
all other reasons
0.84 0.43, 1.65 0.61
Channelopathy vs all other
reasons
0.94 0.49, 1.83 0.86
Cardiomyopathy vs all other
reasons
1.21 0.69, 2.11 0.50
Family history of SCD 1.52 0.82, 2.80 0.18
First degree relative to
family index case
2.24 1.06, 4.75 0.035
SADS Sudden arrhythmic death syndrome SCD Sudden cardiac death.
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or dead) was a positive associate of increased psychological
distress in our analysis. Although it might be thought that
SADS deaths might be most traumatic [24], there is no evi-
dence that different causes of bereavement have different
effects on grief and trauma reactions in young people [26].
We speculate that a closer relationship may mean that the
patient had a better understanding of the event or illness
which affected that person, and may attribute more im-
portance to their screening evaluation. Such proximity may
also mean that these patients might have been more
directly affected by the proband’s illness or sudden death.
These details may be teased out using a qualitative “family
narrative” approach (personal communication, McGuin-
ness S. Lived Lives lost to Suicide: A Visual Art Autopsy
Study of Suicide in Ireland. PhD Thesis, UCD / NUI.
December 2010).
There have been a number of investigations into the
psychological well-being of patients with established car-
diac diseases attending for cardio-genetic counselling
[16,17,25,27,28] and/or specialist disease-related clinic ser-
vices [14,29,30]. Studies have examined HADS findings in
patients with conditions such as HCM [25,31] and DCM
[32]. In these studies, both the HADS-A and HADS-D
measures were higher than those seen in our screening
group. In comparison, it has been shown that patients
with a HCM genotype but with no clinical findings had
better QoL measures that the general public, and were
also less distressed than those gene carriers with structural
cardiac changes [25]. However, these populations differ
from the population described in this study, who were not
known to have a cardiac condition at the time of their psy-
chological testing. Attending for screening for potentially
inheritable cardiac diseases has been shown to be asso-
ciated with psychological stress. Hendricks et al. (2005)
showed that parents of children undergoing genetic test-
ing for LQTS have high levels of psychological distress at
the time of testing, although levels of distress decrease
gradually with time [33]. However the context of scree-
ning is important, with screening in the setting of no
particular family history of cardiac diseases potentially less
stressful. In one study, elite sportsmen screening was not
associated with high levels of distress, with only 3% indi-
cating significant stress on an Impact of Event Scale [15].
Furthermore, the potential personal impact of the
screened condition may be relevant. In a group of patients
attending for familial hypercholesterolaemia screening,
with little change in QoL testing results either over time
or between participants who had a positive (i.e. abnormal)
finding versus those who did not carry the FH gene [17].
A new finding in our analysis was that variation in
measures of psychological well-being was greater be-
tween families than within families. This is an important
finding for clinicians involved in such screening evalua-
tions. It may be that some families may be inherently
predisposed to greater levels of anxiety and depression,
or that the family diagnosis of SCD may be having a
common effect on family members in certain families. In
families with a bereavement, a complicated grief reaction
in a number of family members is a predictor of clinical
depression in the bereaved child or adolescent [34].
Table 7 Multiple regression models examining associations with a clinically significant HADS score
Model 1: Multiple logistic regression Model 2: Multi level multiple logistic regression
Odds ratio 95% CI P value Odds ratio 95% CI P value
Male sex 0.54 0.29, 1.01 0.054 0.52 0.26, 1.03 0.062
Married (vs single/ divorced) 0.42 0.19, 0.92 0.031 0.40 0.17, 0.96 0.040
Third level education or higher 0.31 0.14, 0.71 0.006 0.31 0.13, 0.74 0.009
First degree relative to proband 2.91 1.26, 6.73 0.013 3.18 1.22, 8.31 0.018
Footnote. Multivariable models adjusted for age. Model 1 is a multivariable logistic regression, with a clinically significant HADS score as the outcome variable and
adjusted for age. Model 2 is a multivariable logistic regression model with a random effects variable for family and adjusted for age. Log likelihood for model 1 is
−130.45, and −130.05 for model 2. For the random effects model 2, the random intercept (ψ) is 0.253, and the estimated intraclass correlation of the latent
responses (ρ) is 0.071.
Table 8 Between- and within- family effects on measures of psychological wellbeing and health-related quality of life,
for 316 patients within 135 family groups
Measure Mean Overall standard
deviation
Between-family
standard deviation
Within-family
standard deviation
Hospital anxiety and depression scale
Anxiety scale 6.87 3.95 3.59 2.57
Depression scale 2.83 2.70 2.37 1.79
Short form-12 Health-related quality of life
Physical health component summary 51.62 8.07 7.42 5.51
Mental health component summary 49.63 10.51 9.75 6.61
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Should significant anxiety or depression be present in
one family member, consideration should be given to
assessing psychological well being in other members of
that family also.
Our study presents data on a novel group of patients,
with a high response rate. The two psychometric tests
used showed good internal consistency and appropriate
interscale correlation, and have been used in similar popu-
lations in the past, with the HADS score being previously
validated in a HCM population [35]. Because of the estab-
lished screening utility of the HADS, we used this mea-
sure as our outcome variable in the regression analyses.
Dichotomising the outcome variable reduced the regres-
sion model information, but allowed us present odds
ratios in a clinically useful way. The study was limited by a
lack of contemporary comparator data, and the fact that
the health-related QoL data were collected on one occa-
sion only, with no follow up data available at this time.
For the majority of patients, this was their first clinic visit,
and they had not yet received patient education or genetic
counselling or testing. Neither do we report on psycho-
logical status of patients attending after cascade genetic
screening, as this population of patients is very small in
Ireland at this time. Patients in Ireland typically access
clinical cardiac screening in the first instance. We did not
have complete information on variables such as time
between the family SCD (for those families in which
a SCD had occured) and the screening visit, nor did
we have information on who had discovered the deceased
person. As very small numbers of patients were on any
medical therapy (such as beta blockers), no conclusions
could be drawn as to the putative effects of same on
psychological wellbeing.
These findings have clear implications for cardiac
family-based screening practice. Clinicans should be
aware of the potential for significant psychological
distress in screening patients, and not alone in those
with a family history of a SCD or SADS bereavement.
Closer attention should be afforded families where
one member has elevated anxiety, as it is more likely
that elevated anxiety will be present in other family
members. From our clinical observation, we believe
that patients’ understanding and interpretation of
family risk may be quite different to that of clinicians,
and clinicians should take this variability into account
when conducting screening evaluations. Assessing patient
knowledge, and confronting specific concerns through
patient education, is important for this vulnerable
group.There is an established rationale for a multidiscip-
linary approach to high-risk cardiac screening, with inputs
from multiple health care stakeholders, and the role
of the specialist cardiac screening nurse and the cardiac
genetic counsellor has been endorsed by other authorities
[1,2,16].
Conclusions
High levels of anxiety were seen amongst patients attending
a family-based cardiac screening clinic, even amongst
younger patients, and measures of psychological well-
being and QoL showed less variance within families
than between families.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CMcG, NGM, JON, JG and MC designed the study. CMcG and CMcS
undertook study recruitment, and database and study document design.
CMcG, CMcS and CMcQ performed the data analysis and interpretation.
CMcG, CMcS & CMcQ drafted the manuscript, with all other co-authors
providing comments. All co-authors had access to anonymised study data,
and CMcG takes responsibility for the integrity of the data and the accuracy
of the data analysis. All authors read and approved the final manuscript.
Acknowledgements
This study was funded by the Mater Foundation, through the Mater Heart
Appeal. We acknowledge Quality Metric tm for providing SF-12v2 scores and
scoring software without charge. We acknowledge the assistance of Ms
Brenda Fleming and Ms Catherine O’Donnell throughout the study. The
authors would like to acknowledge their gratitude to the patients for their
participation in this study.
Author details
1The Heart House, Mater Misericordiae University Hospital, Dublin 7, Ireland.
2UCD School of Public Health, Physiotherapy and Population Science,
University College Dublin, Dublin, Ireland. 3Department of Cardiology,
Connolly Hospital, Blanchardstown, Dublin 15, Ireland. 4Department of
Psychiatry and Mental Health Research, St Vincent’s University Hospital,
Dublin 4, Ireland.
Received: 17 May 2012 Accepted: 17 December 2012
Published: 8 January 2013
References
1. Nunn L, Lambiase P: Genetics and cardiovascular disease – cause and
prevention of unexpected sudden adult death: the role of the SADS
clinic. Heart 2011, 97:1122–1127.
2. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ,
Ellinor PT, Gollob M, Hamilton R, et al: HRS/EHRA Expert consensus
statement on the state of genetic testing for the channelopathies and
cardiomyopathies. Hear Rhythm 2011, 8:1308–1339.
3. Ackerman MJ, Tester DJ, Driscoll DJ: Molecular autopsy of sudden
unexplained death in the young. Am J Forensic Med Pathol 2001,
22:105–111.
4. Behr ER, Dalageorgou C, Christiansen M, Syris P, Hughes S, Tome Esteban
MT, Rowland E, Jeffery S, McKenna WJ: Sudden arrhythmic death
syndrome: familial evaluation identifies inheritable heart disease in
majority of families. Eur Heart J 2008, 29:1670–1680.
5. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA: Sudden
unexplained death: heritability and diagnostic yield of cardiological and
genetic examination in surviving relatives. Circulation 2005, 112:207–203.
6. van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal
AC, van Langen IM, Wilde AA: Diagnostic yield in sudden unexplained
death and aborted cardiac arrest in the young: the experience of a
tertiary referral center in The Netherlands. Hear Rhythm 2010,
7:1383–1389.
7. Caldwell J, Moreton N, Khan N, Kerzin-Storrar, Metcalfe K, Newman W,
Garratt CJ: The clinical management of relatives of young sudden
unexplained death victims; implantable defibrillators are rarely indicated.
Heart 2012, 98:631–636.
8. McGorrian C, Constant O, Harper N, O’Donnell C, Codd M, Keelan S, Green
A, O’Neill J, Galvin J, Mahon N: Family-based cardiac screening in relatives of
victims of sudden arrhythmic death syndrome, EP-Europace; 2012. in press.
McGorrian et al. BMC Medical Genetics 2013, 14:1 Page 7 of 8
http://www.biomedcentral.com/1471-2350/14/1
9. Maron BJ: Contemporary insights and strategies for risk stratification and
prevention of sudden death in hypertrophic cardiomyopathy. Circulation
2010, 121:445–456.
10. Goldenberg I, Zareba W, Moss AJ: Long QT Syndrome. Curr Probl Cardiol
2008, 33:629–694.
11. Sen-Chowdhry S, McKenna W: Sudden cardiac death in the young: a
strategy for prevention by targeted evaluation. Cardiology 2006,
105(4):196–206.
12. Parkes CM, Weiss R: Recovery from bereavement. New York: Basic books;
1983.
13. Hendriks KSWH, Hendriks MWB, Birnie E, Grosfeld FJM, Wilde AA, van den
Bout J, Smets EM, van Tintelen JP, ten Kroode HF, van Langen IM: Familial
disease with a risk of sudden death: a longitudinal study of the
psychological consequences of predictive testing for long QT syndrome.
Hear Rhythm 2008, 5:719–724.
14. Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Øyen N: Health status in
patients at risk of inherited arrhythmias and sudden unexpected death
compared to the general population. BMC Med Genet 2010, 11:27.
15. Solberg EE, Bjornstad TH, Andersen TE, Ekeberg O: Cardiovascular
preparticipation screening does not distress professional football
players. Eur J Cardiovasc Prev Rehab 2011, doi:10.1177/1741826711410818.
published online first.
16. Ingles J, Lind JM, Phongsavan P, Semsarian C: Psychosocial impact of
specialized cardiac genetic clinics for hypertrophic cardiomyopathy.
Genet Med 2008, 10(2):117–20.
17. van Maarle MC, Stouthard MEA, Bonsel GJ: Quality of life in a family based
genetic cascade screening programme for familial
hypercholesterolaemia: a longitudinal study among participants. J Med
Genet 2003, 40:e3.
18. Zigmond AS, Snaith PR: The Hospital Anxiety and Depression Scale. Acta
Psychiatr Scand 1983, 67:361–370.
19. Ware JE, Kosinski M, Gandek B, Sundaram M, Bjorner JB, Turner-Bowker DM,
et al: User’s manual for the SF-12v2 Health Survey. 2nd edition. Lincoln, RI:
QualityMetric Incorporated; 2010.
20. Snaith RP: The hospital anxiety and depression scale. Health Qual Life
Outcomes 2003, 1:29.
21. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital
Anxiety and Depression Scale. An updated literature review. J Psychosom
Res 2002, 52:69–77.
22. Cronbach LJ: Coefficient alpha and the internal structure of tests.
Psychometrika 1951, 16:297–333.
23. Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Øyen N: Predictors of
heart-focused anxiety in patients undergoing genetic investigation and
counseling of Long QT syndrome or hypertrophic cardiomyopathy: A
one year follow-up. J Genet Counsel 2012, 21:72–84.
24. Paris MM, Carter BL, Day SX, Armsworth MW: Grief and trauma in children
after the death of a sibling. J Child Adolesc Trauma 2009, 2:71–80.
25. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AAM, Smets EMA:
Quality of life and psychological distress in hypertrophic
cardiomyopathy mutation carriers: A cross sectional cohort study. Am J
Med Genet 2009, 149A:602–612.
26. Lee A, Ackerman MJ: Sudden unexplained death: evaluation of those left
behind. Lancet 2003, 362:1429–1430.
27. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AAM, Smets EMA:
Genetic counseling and cardiac care in predictively tested hypertrophic
cardiomyopathy mutation carriers: The patients’ perspective. Am J Med
Genet 2009, 149A:1444–1451.
28. Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Oyen N: Predictors of
heart-focused anxiety in patients undergoing genetic investigation and
counseling of long QT syndrome or hypertrophic cardiomyopathy: a one
year follow up. J Genet Counsel 2012, 21:72–84.
29. Morgan JF, O’Donoghue AC, McKenna WJ, Schmidt MM: Psychiatric
disorders in hypertrophic cardiomyopathy. Gen Hosp Psychiatry 2008,
30:49–54.
30. Ingles J, Yeates L, Hunt L, McGaughran J, Scuffham PA, Atherton J,
Semsarian C: Health status of cardiac genetic disease patients and their
at-risk relatives. Int J Cardiol 2011, doi:10.1016/j.ijcard.2011.08.083.
31. Cox S, O’Donoghue AC, McKenna, Steptoe A: Health-related quality of life
and psychological wellbeing in patients with hypertrophic
cardiomyopathy. Heart 1997, 78:182–187.
32. Steptoe A, Mohabir A, Mahon NG, McKenna WJ: Health related quality of
life and psychological wellbeing in patients with dilated
cardiomyopathy. Heart 2000, 83:645–650.
33. Hendriks KS, Grosfeld F, van Tintelen J, van Langen I, Wilde A, van den Bout
J, ten Kroode H: Can parents adjust to the idea that their child is at risk
for a sudden death?: Psychological impact of risk for long QT syndrome.
Am J Med Genet 2005, 138A:107–112.
34. Melhelm NM, Porta G, Shamseddeen, Walker Payne M, Brent DA: Grief in
children and adolescents bereaved by sudden parental death. Arch Gen
Psychiatry 2011, 68:911–919.
35. Poole NA, Morgan JF: Validity and reliability of the Hospital Anxiety and
Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a
cardiomyopathy population. Gen Hosp Psychiatry 2006, 28:55–58.
doi:10.1186/1471-2350-14-1
Cite this article as: McGorrian et al.: Family-based associations in
measures of psychological distress and quality of life in a cardiac
screening clinic for inheritable cardiac diseases: a cross-sectional study.
BMC Medical Genetics 2013 14:1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
McGorrian et al. BMC Medical Genetics 2013, 14:1 Page 8 of 8
http://www.biomedcentral.com/1471-2350/14/1
